comparemela.com
Home
Live Updates
Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds : comparemela.com
Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds
San Diego, California (PRWEB) August 20, 2021 -- Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug
Related Keywords
State Of California ,
California ,
United States ,
San Diego ,
Patrick Eckstrom ,
Frank Kochinke ,
Research Advisory Board ,
Us Food Drug Administration ,
United States Drug Enforcement Agency ,
Mycrodose Therapeutics An Advanced Drug Delivery Company ,
Mycrodose Therapeutics ,
Advanced Drug Delivery ,
Chief Science ,
California Attorney General ,
Drug Administration ,
Mycrodose Therapeutic ,
Schedulei License ,
Chad Conner ,
Chief Executive ,
Operating Officer ,
Press Release ,
comparemela.com © 2020. All Rights Reserved.